Institutional Ownership
Biovie Inc
CUSIP 09074F504COM CL A NEWBIVIQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
29
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Diametric Capital, LP | 370.0K | $518.0K |
| 2 | Prelude Capital Management, LLC | 92.1K | $128.9K |
| 3 | Geode Capital Management, LLC | 84.2K | $117.9K |
| 4 | Morgan Stanley | 75.2K | $105.3K |
| 5 | Renaissance Technologies LLC | 67.9K | $95.1K |
| 6 | Citadel Advisors LLC | 45.3K | $63.4K |
| 7 | Jane Street Group, LLC | 22.8K | $31.9K |
| 8 | Xtx Topco Ltd | 21.2K | $29.7K |
| 9 | Northern Trust Corp | 14.2K | $19.9K |
| 10 | Tower Research Capital LLC (Trc) | 7.5K | $10.6K |